EPO and obesity due to melanocortin 4 receptor deficiency: Knock out of the EPO receptor in non-hematopoietic tissues in animal models results in increased fat mass without affecting lean mass [72] and treatment of mice with EPO, or forced EPO overexpression, protects against obesity and improves glucose tolerance [68, 70].